Literature DB >> 23334651

Serum cytokines correlated with the disease severity of generalized pustular psoriasis.

Masaaki Yamamoto1, Yasutomo Imai, Yoshiko Sakaguchi, Takashi Haneda, Kiyofumi Yamanishi.   

Abstract

To characterize serum biomarkers reflecting the severity of generalized pustular psoriasis (GPP), we measured multiple cytokine/chemokine levels in 39 serum samples from 6 cases with GPP during the course of the disease. Serum levels of IL-4, IL-8, CXCL1 and CCL3 were positively correlated with the severity scores of GPP, white blood cell counts and serum C-reactive protein levels. Serum levels of IL-1β, IL-1ra, IL-6, IL-10, IL-12p70, IL-18, IL-22, IFN-γ and VEGF showed strong positive correlations (r>0.4, p<0.01) with all those 3 clinical markers. Of those, IL-10 and IL-22 were significantly decreased after treatment in parallel with the GPP score and therefore those two serum cytokines might be useful to evaluate the efficacy of treatment for GPP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334651      PMCID: PMC3810235          DOI: 10.3233/DMA-120958

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  13 in total

Review 1.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

2.  Epidermal Dysfunction Leads to an Age-Associated Increase in Levels of Serum Inflammatory Cytokines.

Authors:  Lizhi Hu; Theodora M Mauro; Erle Dang; George Man; Jing Zhang; Dale Lee; Gang Wang; Kenneth R Feingold; Peter M Elias; Mao-Qiang Man
Journal:  J Invest Dermatol       Date:  2017-01-20       Impact factor: 8.551

Review 3.  IL-6 as a druggable target in psoriasis: focus on pustular variants.

Authors:  Andrea Saggini; Sergio Chimenti; Andrea Chiricozzi
Journal:  J Immunol Res       Date:  2014-07-13       Impact factor: 4.818

4.  Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?

Authors:  Aleksandra Lesiak; Igor Bednarski; Marta Pałczyńska; Ewelina Kumiszcza; Marzena Kraska-Gacka; Anna Woźniacka; Joanna Narbutt
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

5.  Serum Concentrations of Interferon Gamma (IFN-γ) in Patients with Psoriasis: Correlation with Clinical Type and Severity of the Disease.

Authors:  Nermina Ovcina Kurtovic; Emina Kasumagic Halilovic
Journal:  Med Arch       Date:  2018-12

Review 6.  Genetics of psoriasis and pharmacogenetics of biological drugs.

Authors:  Rocío Prieto-Pérez; Teresa Cabaleiro; Esteban Daudén; Dolores Ochoa; Manuel Roman; Francisco Abad-Santos
Journal:  Autoimmune Dis       Date:  2013-08-28

7.  Generalized pustular psoriasis induced by systemic steroid dose reduction.

Authors:  Danielle Cristine Westphal; Antonio Pedro Mendes Schettini; Petra Pereira de Souza; Jessica Castiel; Carlos Alberto Chirano; Mônica Santos
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

8.  The potential role of Th17 lymphocytes in patients with psoriasis.

Authors:  Mahnaz Mansouri; Parvine Mansouri; Abbas Ali Raze; Zohreh Jadali
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

9.  Circulating Metabolomic Signature in Generalized Pustular Psoriasis Blunts Monocyte Hyperinflammation by Triggering Amino Acid Response.

Authors:  Ning Yu; Chen Peng; Wenjuan Chen; Ziwen Sun; Jianfeng Zheng; Shujie Zhang; Yangfeng Ding; Yuling Shi
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

Review 10.  Clinical Disease Measures in Generalized Pustular Psoriasis.

Authors:  A David Burden; Siew Eng Choon; Alice B Gottlieb; Alexander A Navarini; Richard B Warren
Journal:  Am J Clin Dermatol       Date:  2022-01-21       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.